A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.

@article{Spitler1980ART,
  title={A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.},
  author={Lynn E. Spitler and Richard W. Sagebiel},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={1980},
  volume={9 5},
  pages={736-40}
}
We conducted a randomized double-blind trial of levamisole versus placebo as adjuvant therapy for surgical treatment of melanoma. Of 203 patients entered into the study, 104 received levamisole and 99 placebo. The distribution of prognostic variables was similar in both groups, indicating the efficacy of the randomization and the absence of bias. Three end… CONTINUE READING